TAYLOR KINDER: Open Payments
NPI 1518696020 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 53 payments from 13 companies in 2025. Trend: 2023 $1,720 · 2024 $1,148 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $292 |
| Merck Sharp & Dohme LLC | 10 | $176 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $103 |
| Amgen Inc. | 6 | $90 |
| PFIZER INC. | 4 | $72 |
| Boston Scientific Corporation | 4 | $69 |
| Novo Nordisk Inc | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| HEARTFLOW, INC. | 2 | $38 |
| AtriCure, Inc. | 2 | $33 |
Products named: Kerendia, VERQUVO, LifeVest, REPATHA, WATCHMAN FLX, VYNDAQEL, LEQVIO, FFRct.
Industry payments across KY — which companies pay providers there.
